Monday, March 11, 2013

Look Who’s Attending IIR’s Immunogenicity for Biotherapeutics Event Next Week!

IIR’s 14th Annual Immunogenicity for Biotherapeutics event is three weeks away! We invite you to join the leaders in biologics de-risking, immunoassay validation and predicting immunogenicity in novel, highly complex molecules. Below is just a small portion of who’s already signed up to be in Baltimore March 18-20th:

Companies in attendance include:
*Adnexus * Advion * Alexion Pharmaceuticals * Algorithme Pharma * Allergan * Amgen * Astellas Pharma Global Development * Aushon Biosystems * Avanza Laboratories * Bayer Healthcare * Biogen Idec * Boehringer Ingelheim Pharmaceuticals * Bristol-Myers Squibb * CDER * Charles River Laboratories * CIRION Clinical Trial Services * Clinigene International * Covance * Cytimmune Science * Eleven Biotherapeutics * Eli Lilly & Co. * Emory Children's Center * EpiVax * Food and Drug Administration * Frederick National Lab for Cancer Research * Functional Genetics * Genentech * Genzyme Corp * GlaxoSmithKline * Grifols * Hospira * Ipsen Group * Isis Pharmaceuticals * Janssen * KCAS Bioanalytical Services * Kirin Pharma * MedImmune * PerkinElmer * PharmaNet Development Group * PPD * QPS * Sandoz * Sanofi * Seattle Genetics * SQI Diagnostics * Teva Biopharmaceuticals * WIL Research * and more!

If you’d like to join these companies, the Immunogenicity for Biotherapeutics Conference is taking place next week, March 18-20, 2013, in Baltimore, MD. As a reader of this blog, you receive an exclusive discount of 15% off the standard rate when you register using code XP1838Link.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment